vimarsana.com

DG Capital Management LLC cut its holdings in Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) by 5.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,075,634 shares of the company’s stock after selling 67,465 shares during the period. Fennec Pharmaceuticals accounts […]

Related Keywords

United States ,Robert Andrade ,Adrian Haigh ,Craig Hallum ,Fennec Pharmaceuticals Company Profile ,Fennec Pharmaceuticals ,Securities Exchange Commission ,Capital Management ,Fennec Pharmaceuticals Trading ,Allspring Global Investments Holdings ,Quarter For Fennec Pharmaceuticals ,Dg Capital Management ,Eudaimonia Advisors ,Worth Venture Partners ,Jump Financial ,Exchange Commission ,News Ratings For Fennec Pharmaceuticals Daily ,Fennec Pharmaceuticals Inc ,Free Report ,Venture Partners ,Pharmaceuticals Inc ,Get Free Report ,Sodium Thiosulfate ,Fennec Pharmaceuticals Daily ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.